UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glucagon-like peptide-1, a new hormone of the entero-insular axis

Diabetologia, 1992-08, Vol.35 (8), p.701-711

ØRSKOV, C

1992

Volltextzugriff (PDF)

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem

Neuroscience, 1997-01, Vol.77 (1), p.257-270

1997

Volltextzugriff (PDF)

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice

Gut, 2004-08, Vol.53 (8), p.1145-1150

2004

Volltextzugriff (PDF)

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients

Diabetes care, 1996-06, Vol.19 (6), p.580-586

1996

Volltextzugriff (PDF)

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

Diabetologia, 1993-08, Vol.36 (8), p.741-744

1993

Volltextzugriff (PDF)

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Diabetes (New York, N.Y.), 1994-04, Vol.43 (4), p.535-539

1994

Volltextzugriff (PDF)

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM

Diabetologia, 1996-12, Vol.39 (12), p.1546-1553

1996

Volltextzugriff (PDF)

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I

Diabetes (New York, N.Y.), 1996-06, Vol.45 (6), p.832-835

1996

Volltextzugriff (PDF)

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

The Journal of clinical investigation, 1993, Vol.91 (1), p.301-307

1993

Volltextzugriff (PDF)

IFNγ and Perforin Cooperate to Control Infection and Prevent Fatal Pathology During Persistent Gammaherpesvirus Infection in Mice

Scandinavian journal of immunology, 2014-06, Vol.79 (6), p.395-403

2014

Volltextzugriff (PDF)

The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas

Diabetologia, 2007-10, Vol.50 (10), p.2135-2142

2007

Volltextzugriff (PDF)

GLP-1 does not acutely affect insulin sensitivity in healthy man

Diabetologia, 1996-10, Vol.39 (10), p.1227-1232

1996

Volltextzugriff (PDF)

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

The journal of clinical endocrinology and metabolism, 1993-04, Vol.76 (4), p.912-917

1993

Volltextzugriff (PDF)

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

The Journal of clinical investigation, 1991-02, Vol.87 (2), p.415-423

1991

Volltextzugriff (PDF)

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

The New England journal of medicine, 1992-05, Vol.326 (20), p.1316-1322

1992

Volltextzugriff (PDF)

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach

Endocrinology (Philadelphia), 1988-10, Vol.123 (4), p.2009-2013

1988

Volltextzugriff (PDF)

Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes

International journal of clinical practice (Esher), 2008-12, Vol.62 (12), p.1935-1942

2008

Volltextzugriff (PDF)

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

FEBS letters, 1987-01, Vol.211 (2), p.169-174

1987

Volltextzugriff (PDF)

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes

Current medical research and opinion, 2008-09, Vol.24 (9), p.2651-2661

2008

Volltextzugriff (PDF)

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

Metabolism, clinical and experimental, 1994, Vol.43 (1), p.104-108

1994

Volltextzugriff (PDF)

Nitric Oxide Has Tonic Inhibitory Effect, But Is Not Involved in the Vagal Control or VIP Effects on Motility of the Porcine Antrum

Scandinavian journal of gastroenterology, 2003-09, Vol.38 (9), p.955-961

2003

Volltextzugriff (PDF)

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Diabetes (New York, N.Y.), 1994-04, Vol.43 (4), p.535-539

1994

Volltextzugriff (PDF)

Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose)

Scandinavian journal of gastroenterology, 1995, Vol.30 (9), p.892-896

1995

Volltextzugriff (PDF)

Pancreatic and intestinal processing of proglucagon in man

Diabetologia, 1987-11, Vol.30 (11), p.874-881

1987

Volltextzugriff (PDF)

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

Scandinavian journal of gastroenterology, 1996, Vol.31 (7), p.665-670

1996

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(364)
Mit Volltextzugriff
(291)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(225)
Life Sciences & Biomedicine
(223)
Humans
(188)
Biological And Medical Sciences
(171)
Male
(125)
Female
(116)
Adult
(109)
Medical Sciences
(109)
Animals
(94)
Endocrinology & Metabolism
(93)
Middle Aged
(73)
Fundamental And Applied Biological Sciences. Psychology
(66)
Insulin - Blood
(50)
Glucagon-Like Peptide 1
(46)
Blood Glucose - Metabolism
(43)
Endocrinopathies
(38)
Glucagon - Blood
(33)
Time Factors
(33)
Glucagon-Like Peptides
(31)
Aged
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glucagon-like peptide-1, a new hormone of the entero-insular axis

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

IFNγ and Perforin Cooperate to Control Infection and Prevent Fatal Pathology During Persistent Gammaherpesvirus Infection in Mice

The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas

GLP-1 does not acutely affect insulin sensitivity in healthy man

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach

Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

Nitric Oxide Has Tonic Inhibitory Effect, But Is Not Involved in the Vagal Control or VIP Effects on Motility of the Porcine Antrum

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose)

Pancreatic and intestinal processing of proglucagon in man

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

Suchergebnisse filtern